John Schieszer

Contributing Writer https://www.renalandurologynews.com

John Schieszer is an award winning medical journalist who produces The Medical Minute podcasts. John received his BA in journalism from the University of Missouri-Columbia School of Journalism and his MA in english from the University of Missouri-St. Louis. In 1990, John was awarded the Case Western Reserve University School of Medicine’s Third Annual Fellowship for Journalists in Biomedical Research. In 1992, he completed a Medical Fellowship at the Marine Biological Laboratories in Woods Hole, Massachusetts.

All articles by John Schieszer

DNA autoradiographs. Banded DNA sequences or genetic fingerprints overlapping on a computer screen.

Prostate Cancer

Data May Support Routine Tumor Testing for HRR Gene Alterations in mCRPC

John Schieszer

October 15, 2019

Almost 28% of men with metastatic castration-resistant prostate cancer harbor alterations in homologous recombination repair genes, a study found.

Post-Brachytherapy Erectile Function Preserved in Most Men

Prostate Cancer

Brachytherapy Beneficial in Low-Risk Prostate Cancer, Study Finds

John Schieszer

October 10, 2019

Among men with low-risk prostate cancer, the likelihood of biochemical failure is lower among patients who undergo low-dose-rate brachytherapy vs radical prostatectomy, data suggest.

Various treatments are available for post-prostatectomy erectile dysfunction.

Prostate Cancer

Men With High-Risk PCa and Low PSA May Benefit More From Surgery Than Radiation

John Schieszer

August 22, 2019

In a study, radical prostatectomy for men with Gleason 8-10 prostate cancer and low PSA levels was associated with a lower death risk compared with external beam radiation therapy with or without brachytherapy.

Fracture risk after urolithiasis highest among males aged 10 to 19 years and females aged 30 to 39.

Prostate Cancer

Skeletal-Related Events Common After CRPC Development

John Schieszer

August 13, 2019

Large observational study reveals a 40% cumulative incidence rate of first skeletal-related events following development of castration-resistant prostate cancer.

Prostate Cancer

Risk of Advanced Prostate Cancer Linked to County of Residence

John Schieszer

July 16, 2019

The risk of being diagnosed with advanced prostate cancer varies from place to place in the United States, a new study found.

Prostate Cancer

Neoadjuvant Combo Reduces Volume of High-Risk Prostate Tumors

John Schieszer

June 21, 2019

Abiraterone plus prednisone combined with leuprolide decreases tumor size compared with leuprolide alone in men with high-risk prostate cancer.

Prostate Cancer

PCa Recurrence Predictors in Whole Gland Cryotherapy Identified

John Schieszer

May 28, 2019

Older age and high-risk disease are among the factors independently associated with biochemical recurrence of prostate cancer following whole gland cryotherapy.

Prostate Cancer

Non-Standard Therapies Used in 20% of Localized High-Risk PCa Cases

John Schieszer

May 24, 2019

Using EBRT alone or ADT alone for high-risk localized prostate cancer is associated with worse survival outcomes.

Prostate Cancer

Prostate Cancer ADT Found to Increase Depression Risk

John Schieszer

April 22, 2019

Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.

Prostate Cancer

Adjuvant Docetaxel Possibly Beneficial in High-Risk Prostate Cancer

John Schieszer

April 3, 2019

In a study, adding docetaxel to androgen deprivation and radiation therapy for selected men with high-risk localized prostate cancer improved overall and metastasis-free survival.

Next post in Prostate Cancer